iBio, Inc. (IBIO) KPIs and segments
Close on Nov 17, 2026Market cap $48.11MP/E –Yield –
KPIs & segments
Operating metrics and segments that drive iBio's business
iBio's revenue by segment, product and region, plus the counts and sizes it tags in its 10-K and 10-Q filings (XBRL). Each figure links to the filing it came from. A fuller KPI sheet built from earnings releases and presentations is on the way. See the segment tables for a trailing-twelve-month view, or how companies compare on operating metrics.
The chart is empty. Tick the box next to any metric in the table below to plot it — tick several to compare them on one chart.
iBio's fiscal year ends June 30 — Q4 FY26 = CQ2 2026 (calendar quarter).
| Add to chart | Metric | Q4 FY26 | Q3 FY26 | Q2 FY26 | Q4 FY25 | Q3 FY25 | Q2 FY25 | Q4 FY22 | Q3 FY22 | Q2 FY22 | Q4 FY21 | Q3 FY21 | Q2 FY21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Earlier reporting (last reported 2022)2 | |||||||||||||
Earlier reporting (last reported 2026)1 | |||||||||||||
Earlier reporting (last reported 2022)2 | |||||||||||||
Earlier reporting (last reported 2022)2 | |||||||||||||
Earlier reporting (last reported 2022)2 | |||||||||||||
3 metrics have no data in the last 12 quarters — .
Italic numbers are calculated by StockData from reported figures (hover for the formula). Numbers with a dotted underline are read from the text of earnings releases and presentations; hover to see the exact sentence. Tick a row to add it to the chart above (up to 8 lines).
Methodology and excluded metrics
- Core rows come from the segment and revenue-disaggregation notes of 10-K and 10-Q filings (XBRL), linked to each filing. Fourth-quarter figures are the fiscal year less the first nine months (shown in italic).
Data updated 2026-08-28.
See a number that looks wrong?